Literature DB >> 6243327

Comparison of antibody responses and virus shedding following administration of trivalent oral poliomyelitis vaccines prepared either in monkey or human diploid cell substrates.

D S Freestone, A Kelly, R Ferris, R L Simmons, C Bowker, E Letley, C Bye.   

Abstract

Nineteen (22.9%) of 83 sera collected before vaccination from adult volunteers aged 21-64 years were without neutralizing antibody to poliomyelitis at levels of 0.15 i.u./ml for types I and II and 0.1 i.u./ml for type III. Some correlations were found between the history of previous vaccination and the presence of antibody but these were not well defined. Vaccination with a single dose of trivalent oral polio vaccine elicited fourfold or greater antibody responses to one or more poliomyelitis types in 53 (63.9%) volunteers, the percentage antibody resposnes being inversely related to the titre of antibody present before vaccination. Types I, II or III poliomyelitis virus were recovered from 76.8% of faecal samples collected 1 week after vaccination. The percentage recovery progressively declined thereafter until virus was recovered from 10.5% of samples collected 6 weeks after vaccination. Type for type, the titres and percentages of antibody responses and virus shedding in faeces were similar following trivalent oral poliomyelitis vaccines whether prepared in monkey or human diploid cell substrates. Some change in reproductive capacity temperature (r.c.t./40) marker was found in faecal isolates from volunteers vaccinated with monkey kidney and human diploid grown vaccines but no change in 'd' marker was found.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6243327      PMCID: PMC2133822          DOI: 10.1017/s0022172400026474

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  11 in total

1.  Effect of a single dose of oral poliovirus vaccine in persons previously immunized with inactivated vaccine.

Authors:  D HOBSON; J M HOSKINS; C A LANE; F T PERKINS; R YETTS
Journal:  Br Med J       Date:  1962-06-21

2.  The serial cultivation of human diploid cell strains.

Authors:  L HAYFLICK; P S MOORHEAD
Journal:  Exp Cell Res       Date:  1961-12       Impact factor: 3.905

3.  British standard poliomyelitis antisera types 1, 2, and 3.

Authors:  F T PERKINS; D G EVANS
Journal:  Br Med J       Date:  1959-06-20

4.  Present position of immunization against poliomyelitis with live virus vaccines.

Authors:  A B SABIN
Journal:  Br Med J       Date:  1959-03-14

5.  Properties and behavior of orally administered attenuated poliovirus vaccine.

Authors:  A B SABIN
Journal:  J Am Med Assoc       Date:  1957-07-13

6.  The response to oral poliovaccine in persons aged 16-18 years.

Authors:  J W Smith; J A Lee; W B Fletcher; C A Morris; D A Parker; R Yetts; D I Magrathe; F T Perkins
Journal:  J Hyg (Lond)       Date:  1976-04

7.  Sero-immunity to poliovirus in children and young women: England 1972-4.

Authors:  P P Mortimer; P Cunningham
Journal:  J Hyg (Lond)       Date:  1975-04

Review 8.  Control of influenza and poliomyelitis with killed virus vaccines.

Authors:  J Salk; D Salk
Journal:  Science       Date:  1977-03-04       Impact factor: 47.728

Review 9.  Immunization against poliomyelitis.

Authors:  A J Beale
Journal:  Br Med Bull       Date:  1969-05       Impact factor: 4.291

10.  Evolution of poliovirus since introduction of attenuated vaccine.

Authors:  Y E Cossart
Journal:  Br Med J       Date:  1977-06-25
View more
  1 in total

1.  Poliomyelitis immunity status at different intervals from vaccination.

Authors:  E Bellelli; U Bracchi; M L Tanzi; G Benaglia; G Montanarini
Journal:  Eur J Epidemiol       Date:  1986-09       Impact factor: 8.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.